Twitter LinkedIn
    Thursday, March 23
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Mergers and acquisitions»Swander Pace Capital completes sale of Clarion Brands to Bridges Consumer Healthcare
    Mergers and acquisitions

    Swander Pace Capital completes sale of Clarion Brands to Bridges Consumer Healthcare

    January 24, 2021Updated:January 24, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Swander Pace Capital (SPC) has completed the sale of Clarion Brands, a consumer products company specialising in over-the-counter (OTC) healthcare solutions and dietary supplements, to Bridges Consumer Healthcare LLC, a consumer healthcare company partnering with Charlesbank Capital Partners.

    Clarion markets a portfolio of leading niche OTC and dietary supplements brands that are sold to food, drug, mass, and online retailers throughout the United States and Canada.

    Swander Pace Capital partnered with the former management team of Insight Pharmaceuticals following its sale to Prestige Brands Holdings in 2014, and created the Clarion consumer healthcare platform. Under the ownership of SPC, Clarion built its product portfolio of seven brands specializing in over-the-counter healthcare solutions, including three No1 healthcare professional (“HCP”) recommended brands: Florajen Probiotics, the No1 pharmacist recommended probiotic brand where carried, Lipo-Flavonoid, the No1 ENT doctor recommended OTC product for ringing in the ears (tinnitus) and Certain Dri, the No1 doctor recommended OTC brand for controlling excessive underarm sweating (hyperhidrosis).

    “The SPC team was essential in providing the guidance and financial support to grow our business, and it’s been our pleasure to work with them through two very successful transactions,” says Gary Downing, CEO of Clarion. “Our work together has helped accelerate our value creation initiatives, including new product innovation, growth with our retail partners, unique HCP outreach initiatives and aggressive efforts to build out e-commerce channels.”

    “We are very proud to have partnered with Gary and the Clarion team for another successful investment in the OTC category,” says Mo Stout, Managing Director at Swander Pace Capital. “Through significant brand development, innovation, and operational execution, we were able to create a best-in-class OTC platform company. We want to thank the entire Clarion team for all of their hard work during our ownership, and we look forward to watching the brands continue to grow and flourish as part of the Bridges organisation.”

    Sawaya Partners, LLC served as exclusive financial advisor to Clarion and Swander Pace Capital, and Kirkland & Ellis LLP acted as legal counsel to Clarion and Swander Pace Capital on the transaction.

     

    Source: Private Equity Wire

     

    Image Source
    Image Source

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals and transactions Mergers and acquisitions Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    UBS Agrees to Buy Credit Suisse for $3 Billion in Historic Deal – Copy

    March 19, 2023

    UBS Agrees to Buy Credit Suisse for $3 Billion in Historic Deal

    March 19, 2023

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    Comments are closed.

    Other Articles

    Prudential makes USD200m commitment to diversity

    August 21, 2021

    SPACs impacting autotech exit market, says Hampleton Partners

    March 19, 2021

    TA Associates makes strategic growth investment in Nactarome

    November 26, 2021

    Silver Lake and Nestlé lead €3.5bn investment in vet group IVC Evidensia

    February 13, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?